EP2968290
Tímabundin vernd eðlilegra frumna meðan á lyfjameðferð stendur
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.3.2014EP published:
25.9.2019EP application number:
14762438.1
EP translation filed:
25.11.2019Grant published:
15.12.2019EPO information:
European Patent Register
Max expiry date:
13.3.2034Expiry date:
13.3.2027Next due date:
31.3.2027
Title:
TRANSIENT PROTECTION OF NORMAL CELLS DURING CHEMOTHERAPY
Timeline
Today
14.3.2014EP application
25.9.2019EP Publication
25.11.2019Translation submitted
15.12.2019Registration published
13.3.2027Expires
Owner
Name:
G1 Therapeutics, Inc.Address:
79 T.W. Alexander Drive, 4501 Research Commons, Suite 100, 27709, Research Triangle Park, NC, US
Inventor
Name:
STRUM, Jay, CopelandAddress:
Chapel Hill, NC, US
Name:
BISI, John, EmersonAddress:
Chapel Hill, NC, US
Name:
ROBERTS, Patrick, JosephAddress:
Chapel Hill, NC, US
Name:
TAVARES, Francis, XavierAddress:
Chapel Hill, NC, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361798772 PDate:
15.3.2013Country:
US
Number:
201361861374 PDate:
1.8.2013Country:
US
Number:
201361911354 PDate:
3.12.2013Country:
US
Number:
201461949786 PDate:
7.3.2014Country:
US
Classification
Categories:
A61K 31/44, C07D 491/14, A61K 31/527, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.2.2020
Expires: 13.3.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.2.2021
Expires: 13.3.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.2.2022
Expires: 13.3.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 8.2.2023
Expires: 13.3.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.2.2024
Expires: 13.3.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.2.2025
Expires: 13.3.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.3.2026
Expires: 13.3.2027
Payer: Árnason Faktor ehf.